An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study

Novartis Investigative Site, Sydney

Novartis Investigative Site, Parramatta

Novartis Investigative Site, Hurstville

Novartis Investigative Site, Albury

Novartis Investigative Site, Glen Waverley

Novartis Investigative Site, Rowville

Novartis Investigative Site, Hasselt

Novartis Investigative Site, Binningen

Novartis Investigative Site, Nedlands

Novartis Investigative Site, Taipei

Novartis Investigative Site, Prague

Novartis Investigative Site, Bundang Gu

Novartis Investigative Site, Córdoba

Novartis Investigative Site, Pamplona

Novartis Investigative Site, Bordeaux

Novartis Investigative Site, Taoyuan District

Novartis Investigative Site, Fort Lauderdale

Novartis Investigative Site, Saint-Cyr-sur-Loire

Novartis Investigative Site, Germantown

Novartis Investigative Site, Shah Alam

Novartis Investigative Site, Nantes

Novartis Investigative Site, Burjassot

Novartis Investigative Site, Indianapolis

Novartis Investigative Site, Busan

Novartis Investigative Site, Zaragoza

Novartis Investigative Site, Ramat Gan

Novartis Investigative Site, Mainz

Novartis Investigative Site, Minneapolis

Novartis Investigative Site, Batu Caves

Novartis Investigative Site, Lyon

Novartis Investigative Site, Västerås

Novartis Investigative Site, Malacca

Novartis Investigative Site, Paris

Novartis Investigative Site, Paris

Novartis Investigative Site, Freiburg im Breisgau

Novartis Investigative Site, Montauban

Novartis Investigative Site, Rueil-Malmaison

Novartis Investigative Site, Huntington Beach

Novartis Investigative Site, Créteil

Novartis Investigative Site, Taipei

Novartis Investigative Site, Daegu

Novartis Investigative Site, Ẕerifin

Novartis Investigative Site, Jerusalem

Novartis Investigative Site, Hradec Králové

Novartis Investigative Site, Prague

Novartis Investigative Site, Marseille

Novartis Investigative Site, Leipzig

Novartis Investigative Site, Perugia

Novartis Investigative Site, 's-Hertogenbosch

Novartis Investigative Site, Nijmegen

Novartis Investigative Site, Porto

Novartis Investigative Site, Vila Franca de Xira

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, Seoul

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Sant Cugat del Vallès

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Örebro